JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 6, 2003; DOI: 10.1124/jpet.103.050666


0022-3565/03/3062-546-555$20.00
JPET 306:546-555, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.050666v1
306/2/546    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Möykkynen, T.
Right arrow Articles by Lovinger, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Möykkynen, T.
Right arrow Articles by Lovinger, D. M.

NEUROPHARMACOLOGY

Ethanol Inhibits {alpha}-Amino-3-hydyroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Function in Central Nervous System Neurons by Stabilizing Desensitization

Tommi Möykkynen, Esa R. Korpi, and David M. Lovinger

Department of Molecular Physiology and Biophysics (T.M., D.M.L.), Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Pharmacology and Clinical Pharmacology (T.M., E.R.K.), University of Turku, Turku, Finland; Institute of Biomedicine (E.R.K.), Pharmacology, University of Helsinki, Helsinki, Finland; and Laboratory for Integrative Neuroscience (D.M.L.), National Institute on Alcohol Abuse and Alcoholism, Rockville, Maryland

Ethanol actions on {alpha}-amino-3-hydyroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors were studied using voltage-clamp recordings from mouse cortical and hippocampal neurons. During whole-cell recordings ethanol (EtOH) inhibited AMPA receptor-mediated currents in a dose-dependent manner at concentrations from 10 to 500 mM. The steady-state component of AMPA-activated current was more sensitive to EtOH than the peak component. To examine the effect of EtOH on a well resolved peak current component, patches were excised from cultured cortical neurons, to which AMPA and EtOH were applied using a piezoelectric solution application system. Under this condition, the peak current was not inhibited significantly by EtOH. To further study possible mechanisms of EtOH inhibition, kainate and AMPA were used to evoke currents in the absence and presence of cyclothiazide. Ethanol inhibition was stronger when receptors were activated by low than high kainate concentrations. Cyclothiazide reduced inhibition by EtOH regardless of the agonist used to activate the receptor. Finally, EtOH inhibition was reduced in a point mutated (L497Y) GluRAi receptor that lacks desensitization. These findings suggest that EtOH inhibits AMPA receptors by stabilizing the desensitized state. Our results can explain some of the variation observed in EtOH inhibition in previous studies, and support the idea that physiologically relevant concentrations of EtOH can have a strong effect on AMPA receptor function.


Received for publication February 19, 2003
Accepted May 6, 2003.

Address correspondence to: Dr. David M. Lovinger, Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, 12420 Parklawn Dr., Rockville, MD 20852. E-mail: lovindav{at}mail.nih.gov




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
A. M. Dopico and D. M. Lovinger
Acute Alcohol Action and Desensitization of Ligand-Gated Ion Channels
Pharmacol. Rev., March 1, 2009; 61(1): 98 - 114.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. K. Coleman, T. Moykkynen, A. Jouppila, S. Koskelainen, C. Rivera, E. R Korpi, and K. Keinanen
Agonist Occupancy Is Essential for Forward Trafficking of AMPA Receptors
J. Neurosci., January 14, 2009; 29(2): 303 - 312.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Liu, T. Vaithianathan, K. Manivannan, A. Parrill, and A. M. Dopico
Ethanol Modulates BKCa Channels by Acting as an Adjuvant of Calcium
Mol. Pharmacol., September 1, 2008; 74(3): 628 - 640.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Ren, A. K. Salous, J. M. Paul, K. A. Lamb, D. S. Dwyer, and R. W. Peoples
Functional Interactions of Alcohol-sensitive Sites in the N-Methyl-D-aspartate Receptor M3 and M4 Domains
J. Biol. Chem., March 28, 2008; 283(13): 8250 - 8257.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
W. Zhu, B. Bie, and Z. Z. Pan
Involvement of Non-NMDA Glutamate Receptors in Central Amygdala in Synaptic Actions of Ethanol and Ethanol-Induced Reward Behavior
J. Neurosci., January 10, 2007; 27(2): 289 - 298.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. K. Coleman, T. Moykkynen, C. Cai, L. von Ossowski, E. Kuismanen, E. R. Korpi, and K. Keinanen
Isoform-Specific Early Trafficking of AMPA Receptor Flip and Flop Variants
J. Neurosci., October 25, 2006; 26(43): 11220 - 11229.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Carta, M. Mameli, and C. F. Valenzuela
Alcohol Potently Modulates Climbing Fiber->Purkinje Neuron Synapses: Role of Metabotropic Glutamate Receptors
J. Neurosci., February 15, 2006; 26(7): 1906 - 1912.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Mameli, P. A. Zamudio, M. Carta, and C. F. Valenzuela
Developmentally Regulated Actions of Alcohol on Hippocampal Glutamatergic Transmission
J. Neurosci., August 31, 2005; 25(35): 8027 - 8036.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.